Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SELPERCATINIB
(2020)
Small molecule
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor
Unknown
Approved
Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Neoplasms; Thyroid Neoplasms
SELPERCATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
CEGM9YBNGD
Molecule Type:
Small molecule
Molecular Formula:
C29H31N7O3
Molecular Weight:
525.61
AlogP:
3.28
PSA:
112.04
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OPICAPONE
(2020)
Small molecule
Catechol O-methyltransferase inhibitor
Unknown
Approved
Parkinson Disease
OPICAPONE
×
Maximum Phase:
4
First Approval:
2020
UNII:
Y5929UIJ5N
Molecule Type:
Small molecule
Molecular Formula:
C15H10Cl2N4O6
Molecular Weight:
413.17
AlogP:
3.28
PSA:
149.46
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BEROTRALSTAT
(2020)
Small molecule
Unknown
Unknown
Approved
Angioedemas, Hereditary
BEROTRALSTAT
×
Maximum Phase:
4
First Approval:
2020
UNII:
XZA0KB1BDQ
Molecule Type:
Small molecule
Molecular Formula:
C30H26F4N6O
Molecular Weight:
562.57
AlogP:
5.7
PSA:
108.76
HBD:
3.0
HBA:
#RotB:
9.0
Source:
RISDIPLAM
(2020)
Small molecule
SMN2 pre-mRNA positive modulator
Unknown
Approved
Atrophy; Muscular Atrophy, Spinal
RISDIPLAM
×
Maximum Phase:
4
First Approval:
2020
UNII:
76RS4S2ET1
Molecule Type:
Small molecule
Molecular Formula:
C22H23N7O
Molecular Weight:
401.47
AlogP:
1.96
PSA:
79.83
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NIFURTIMOX
(2020)
Small molecule
DNA inhibitor
Unknown
Approved
Chagas Disease; Leishmaniasis; Trypanosomiasis
NIFURTIMOX
×
Maximum Phase:
4
First Approval:
2020
UNII:
M84I3K7C2O
Molecule Type:
Small molecule
Molecular Formula:
C10H13N3O5S
Molecular Weight:
287.3
AlogP:
0.64
PSA:
106.02
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PRALSETINIB
(2020)
Small molecule
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor
Unknown
Approved
Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Neoplasms
PRALSETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
1WPE73O1WV
Molecule Type:
Small molecule
Molecular Formula:
C27H32FN9O2
Molecular Weight:
533.61
AlogP:
4.2
PSA:
135.53
HBD:
3.0
HBA:
#RotB:
8.0
Source:
AMISULPRIDE
(2020)
Small molecule
Dopamine receptors; D2 & D3 antagonist
Unknown
Approved
Postoperative Nausea and Vomiting; Psychotic Disorders
AMISULPRIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
8110R61I4U
Molecule Type:
Small molecule
Molecular Formula:
C17H27N3O4S
Molecular Weight:
369.49
AlogP:
1.29
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
7.0
Source:
FLUOROESTRADIOL
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
FLUOROESTRADIOL
×
Maximum Phase:
4
First Approval:
2020
UNII:
LVI5P34A3C
Molecule Type:
Small molecule
Molecular Formula:
C18H23FO2
Molecular Weight:
290.38
AlogP:
3.56
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
TAZEMETOSTAT
(2020)
Small molecule
Unknown
Unknown
Approved
Neoplasms
TAZEMETOSTAT
×
Maximum Phase:
4
First Approval:
2020
UNII:
Q40W93WPE1
Molecule Type:
Small molecule
Molecular Formula:
C34H44N4O4
Molecular Weight:
572.75
AlogP:
4.73
PSA:
86.9
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VIBEGRON
(2020)
Small molecule
Beta-3 adrenergic receptor agonist
Unknown
Approved
Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Urge
VIBEGRON
×
Maximum Phase:
4
First Approval:
2020
UNII:
M5TSE03W5U
Molecule Type:
Small molecule
Molecular Formula:
C26H28N4O3
Molecular Weight:
444.54
AlogP:
2.77
PSA:
96.25
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FOSTEMSAVIR TROMETHAMINE
(2020)
Small molecule
Envelope polyprotein GP160 inhibitor
Unknown
Approved
Autoimmune Diseases; HIV Infections
FOSTEMSAVIR TROMETHAMINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
2X513P36U0
Molecule Type:
Small molecule
Molecular Formula:
C29H37N8O11P
Molecular Weight:
704.63
AlogP:
1.17
PSA:
182.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TUCATINIB
(2020)
Small molecule
Receptor protein-tyrosine kinase erbB-2 inhibitor
Unknown
Approved
Brain Neoplasms; Breast Neoplasms; Neoplasms
TUCATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
234248D0HH
Molecule Type:
Small molecule
Molecular Formula:
C26H24N8O2
Molecular Weight:
480.53
AlogP:
5.09
PSA:
110.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FOSTEMSAVIR
(2020)
Small molecule
Envelope polyprotein GP160 inhibitor
Unknown
Approved
HIV Infections; Virus Diseases
FOSTEMSAVIR
×
Maximum Phase:
4
First Approval:
2020
UNII:
97IQ273H4L
Molecule Type:
Small molecule
Molecular Formula:
C25H26N7O8P
Molecular Weight:
583.5
AlogP:
1.17
PSA:
182.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
OLICERIDINE
(2020)
Small molecule
Mu opioid receptor agonist
Unknown
Approved
Acute Pain; Pain
OLICERIDINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
MCN858TCP0
Molecule Type:
Small molecule
Molecular Formula:
C22H30N2O2S
Molecular Weight:
386.56
AlogP:
4.69
PSA:
43.38
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLASCOTERONE
(2020)
Small molecule
Androgen Receptor antagonist
Unknown
Approved
Acne Vulgaris
CLASCOTERONE
×
Maximum Phase:
4
First Approval:
2020
UNII:
XN7MM8XG2M
Molecule Type:
Small molecule
Molecular Formula:
C24H34O5
Molecular Weight:
402.53
AlogP:
3.77
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SOMAPACITAN
(2020)
Small molecule
Growth hormone receptor agonist
Unknown
Approved
Unknown
SOMAPACITAN
×
Maximum Phase:
4
First Approval:
2020
UNII:
8FOJ430U94
Molecule Type:
Small molecule
Molecular Formula:
C55H97N13O19S2
Molecular Weight:
1308.59
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CENOBAMATE
(2020)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
Unknown
Approved
Epilepsy; Seizures
CENOBAMATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
P85X70RZWS
Molecule Type:
Small molecule
Molecular Formula:
C10H10ClN5O2
Molecular Weight:
267.68
AlogP:
1.16
PSA:
95.92
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RELUGOLIX
(2020)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
Unknown
Approved
Neoplasms; Prostatic Neoplasms
RELUGOLIX
×
Maximum Phase:
4
First Approval:
2020
UNII:
P76B05O5V6
Molecule Type:
Small molecule
Molecular Formula:
C29H27F2N7O5S
Molecular Weight:
623.64
AlogP:
3.75
PSA:
132.61
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LACTITOL
(2020)
Small molecule
Osmotic agent
Unknown
Approved
Constipation
LACTITOL
×
Maximum Phase:
4
First Approval:
2020
UNII:
L2B0WJF7ZY
Molecule Type:
Small molecule
Molecular Formula:
C12H24O11
Molecular Weight:
344.31
AlogP:
-5.76
PSA:
200.53
HBD:
9.0
HBA:
#RotB:
8.0
Source:
TAZEMETOSTAT HYDROBROMIDE
(2020)
Small molecule
Histone-lysine N-methyltransferase EZH2 inhibitor
Unknown
Approved
Lymphoma, Follicular; Sarcoma
TAZEMETOSTAT HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
6P89T5M073
Molecule Type:
Small molecule
Molecular Formula:
C34H45BrN4O4
Molecular Weight:
653.66
AlogP:
4.73
PSA:
86.9
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LONAFARNIB
(2020)
Small molecule
Protein farnesyltransferase inhibitor
Unknown
Approved
Progeria
LONAFARNIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
IOW153004F
Molecule Type:
Small molecule
Molecular Formula:
C27H31Br2ClN4O2
Molecular Weight:
638.83
AlogP:
5.91
PSA:
79.53
HBD:
1.0
HBA:
#RotB:
3.0
Source:
REMIMAZOLAM BESYLATE
(2020)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
Unknown
Approved
Unknown
REMIMAZOLAM BESYLATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
280XQ6482H
Molecule Type:
Small molecule
Molecular Formula:
C27H25BrN4O5S
Molecular Weight:
597.49
AlogP:
4.18
PSA:
69.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FENFLURAMINE
(2020)
Small molecule
Unknown
Unknown
Approved
Epilepsy; Obesity
FENFLURAMINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
2DS058H2CF
Molecule Type:
Small molecule
Molecular Formula:
C12H16F3N
Molecular Weight:
231.26
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CAPMATINIB HYDROCHLORIDE
(2020)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Approved
Carcinoma, Non-Small-Cell Lung
CAPMATINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
C2A374O70X
Molecule Type:
Small molecule
Molecular Formula:
C23H21Cl2FN6O2
Molecular Weight:
503.37
AlogP:
3.43
PSA:
85.07
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIMEGEPANT SULFATE
(2020)
Small molecule
Calcitonin gene-related peptide type 1 receptor antagonist
Unknown
Approved
Migraine Disorders
RIMEGEPANT SULFATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
1383NM3Q0H
Molecule Type:
Small molecule
Molecular Formula:
C56H64F4N12O13S
Molecular Weight:
1221.26
AlogP:
4.49
PSA:
119.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TIRBANIBULIN
(2020)
Small molecule
Tyrosine-protein kinase SRC inhibitor
Unknown
Approved
Keratosis, Actinic
TIRBANIBULIN
×
Maximum Phase:
4
First Approval:
2020
UNII:
4V9848RS5G
Molecule Type:
Small molecule
Molecular Formula:
C26H29N3O3
Molecular Weight:
431.54
AlogP:
3.32
PSA:
63.69
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LASMIDITAN SUCCINATE
(2020)
Small molecule
Serotonin 1f (5-HT1f) receptor agonist
Unknown
Approved
Migraine Disorders
LASMIDITAN SUCCINATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
W64YBJ346B
Molecule Type:
Small molecule
Molecular Formula:
C42H42F6N6O8
Molecular Weight:
872.82
AlogP:
3.28
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SELUMETINIB
(2020)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Approved
Neoplasms
SELUMETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
6UH91I579U
Molecule Type:
Small molecule
Molecular Formula:
C17H15BrClFN4O3
Molecular Weight:
457.69
AlogP:
3.53
PSA:
88.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
LEMBOREXANT
(2020)
Small molecule
Orexin receptor 1 antagonist
Unknown
Approved
Sleep Initiation and Maintenance Disorders
LEMBOREXANT
×
Maximum Phase:
4
First Approval:
2020
UNII:
0K5743G68X
Molecule Type:
Small molecule
Molecular Formula:
C22H20F2N4O2
Molecular Weight:
410.42
AlogP:
3.74
PSA:
77.0
HBD:
1.0
HBA:
#RotB:
6.0
Source:
FLUOROESTRADIOL F-18
(2020)
Small molecule
Diagnostic agent
Unknown
Approved
Breast Neoplasms
FLUOROESTRADIOL F-18
×
Maximum Phase:
4
First Approval:
2020
UNII:
T32277KB09
Molecule Type:
Small molecule
Molecular Formula:
C18H23FO2
Molecular Weight:
289.38
AlogP:
3.56
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
POTASSIUM OXYBATE
(2020)
Small molecule
GABA-B receptor agonist
Unknown
Approved
Unknown
POTASSIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
S8NKF3H3KT
Molecule Type:
Small molecule
Molecular Formula:
C4H7KO3
Molecular Weight:
142.19
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BEMPEDOIC ACID
(2020)
Small molecule
ATP-citrate synthase inhibitor
Unknown
Approved
Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Hyperlipoproteinemia Type II
BEMPEDOIC ACID
×
Maximum Phase:
4
First Approval:
2020
UNII:
1EJ6Z6Q368
Molecule Type:
Small molecule
Molecular Formula:
C19H36O5
Molecular Weight:
344.49
AlogP:
4.47
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
14.0
Source:
RIMEGEPANT
(2020)
Small molecule
Calcitonin gene-related peptide type 1 receptor antagonist
Unknown
Approved
Migraine Disorders
RIMEGEPANT
×
Maximum Phase:
4
First Approval:
2020
UNII:
997WVV895X
Molecule Type:
Small molecule
Molecular Formula:
C28H28F2N6O3
Molecular Weight:
534.57
AlogP:
4.49
PSA:
119.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TRIHEPTANOIN
(2020)
Small molecule
Supplement
Unknown
Approved
Unknown
TRIHEPTANOIN
×
Maximum Phase:
4
First Approval:
2020
UNII:
2P6O7CFW5K
Molecule Type:
Small molecule
Molecular Formula:
C24H44O6
Molecular Weight:
428.61
AlogP:
5.9
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
20.0
Source:
ARTESUNATE
(2020)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTESUNATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
60W3249T9M
Molecule Type:
Small molecule
Molecular Formula:
C19H28O8
Molecular Weight:
384.43
AlogP:
2.6
PSA:
100.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIPRETINIB
(2020)
Small molecule
Platelet-derived growth factor receptor alpha inhibitor
Unknown
Approved
Gastrointestinal Stromal Tumors; Neoplasms
RIPRETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
9XW757O13D
Molecule Type:
Small molecule
Molecular Formula:
C24H21BrFN5O2
Molecular Weight:
510.37
AlogP:
5.67
PSA:
88.05
HBD:
3.0
HBA:
#RotB:
5.0
Source:
1
2
…
71
72
73
74
75
76
77
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA